Mr. Tunc Tiryaki

Consultant Plastic Surgeon / GMC: 7497351

Mr Tunc Tiryaki is a Consultant Plastic Surgeon specialising in facial surgery. Mr Tiryaki has a special interest in stem cell assisted mini face lifts and is a pioneer in minimally invasive cosmetic procedures including suspension techniques, micro-lifting and regenerative cell injections – all delivering exceptionally natural results.

Mr Tiryaki is renowned by peers and patients as one of the world's most pre-eminent surgeons and holds patents for his innovative techniques in regenerative and plastic surgery. Lecturing all of the world, Mr Tiryaki is passionate about education, sharing his knowledge and contributing to the future of cosmetic surgery.

Mr. Tunc Tiryaki

Widely published, Mr Tiryaki has been recognised with many awards and honours, including Best Global Paper Award at the World Congress of the Aesthetic Surgery Society in Melbourne 2008 for his paper, Shuttle Lifting of the Face.

Mr Tiryaki is the Chair of Humanitarian Programs of ISAPS (International Society of Aesthetic and Plastic Surgeons) and undertakes extensive work as a humanitarian, actively leading and joining surgical volunteer missions to countries including Syria, Sudan, Kazakhstan and Georgia as well as having lead rescue missions during the 1999 and 2011 earthquakes in Turkey.

He is the editor of the recent international 'Inverse Abdominoplasty' textbook, as well as the co-author of the Stem Cell Therapies chapter of a major two-volume textbook in plastic surgery. Having many international publications and patents for novel techniques in regenerative and plastic surgery, Mr Tiryaki is also serving as 'Section Editor' of the International Aesthetic Plastic Surgery Journal.

Mr. Tunc Tiryaki Results

Click here to view the gallery of Mr. Tunc Tiryaki before and after images.

Research led by Mr. Tunc Tiryaki

  • Staged stem cell-enriched tissue (SET) injections for soft tissue augmentation in hostile recipient areas: a preliminary report.
  • The effect of cultured autologous fibroblasts on longevity of cross-linked hyaluronic acid used as a filler.

Specialist Treatments

Related News